Isomorphic Labs Unveils Exclusive New AI Drug Discovery Model Ahead of AlphaFold 4
Isomorphic Labs, the DeepMind spin-off focused on AI-driven drug discovery, has revealed an exclusive new AI model that scientists say surpasses current benchmarks, offering a glimpse of what AlphaFold 4 may bring to pharmaceutical research and molecular biology.